holding glp 1 prior to surgery Are Serious Anesthesia Risks of Semaglutide and Other GLP-1 Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia With Even More Powerful GLP-1s
Description
If you are looking specifically for semaglutide dosing at weight loss levels (1.7 mg or 2.4 mg), you may need to call ahead to confirm availability
This could improve access and reduce hesitation around injectable treatments
Clinical trials show constipation occurs in approximately 11-24% of patients taking semaglutide and 6-11% taking tirzepatide, compared to 11% in placebo groups
(2011) 301:H218190
, Mojsov, S
For everyday post-meal bloat, it's an easy recommend
